World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
24437
World Ranking
16127
National Ranking
534

Madeleine King publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Madeleine King sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 374 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Madeleine King D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Madeleine King sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Madeleine King is affiliated with the University of Sydney in Australia. Their research spans several fields with a focus on Medicine and Economics, Econometrics and Finance. Their work often intersects oncology and health systems, emphasizing economic evaluations and quality of life in cancer care.

King has contributed to multiple topics within their fields of study, which include:

  • Health Systems, Economic Evaluations, Quality of Life
  • Cancer survivorship and care
  • Economic and Financial Impacts of Cancer
  • Frailty in Older Adults
  • Childhood Cancer Survivors' Quality of Life
  • Ovarian cancer diagnosis and treatment
  • Palliative Care and End-of-Life Issues

Their frequent publication venues reflect a strong focus on quality of life and oncology, with multiple publications in these journals:

  • Quality of Life Research
  • Journal of Clinical Oncology
  • Journal of Patient-Reported Outcomes
  • Gynecologic Oncology
  • The Lancet Oncology

Some of the recent papers featuring their work include:

  • "International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium" (2020), published in The Lancet Oncology
  • "Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial" (2022), published in The Lancet Healthy Longevity
  • "Perceived benefits and limitations of using patient-reported outcome measures in clinical practice with individual patients: a systematic review of qualitative studies" (2021), published in Quality of Life Research
  • "Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial" (2023), published in The Lancet Oncology
  • "Integrated geriatric assessment and treatment (INTEGERATE) in older people with cancer planned for systemic anticancer therapy." (2020), published in Journal of Clinical Oncology

King's collaborative network includes frequent co-authors, indicative of a broad and interdisciplinary research approach. Notable co-authors with whom King has published extensively are:

  • Richard Norman
  • Andrew Bottomley
  • Claudia Rutherford
  • Rebecca Mercieca-Bebber
  • Galina Velikova

Their work integrates clinical research with health economics, focusing heavily on patient-centered outcomes in oncology and geriatric cancer care. The interdisciplinary nature of their research aims to improve understanding of cancer survivorship, treatment effectiveness in older populations, and the economic impacts related to cancer management strategies.

Best Publications

  • The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30

    M. T King

  • Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.

    Melanie Calvert;Derek Kyte;Rebecca Mercieca-Bebber;Anita Slade

  • Caring for Aged Dementia Care Resident Study (CADRES) of Person-Centred Care, Dementia-Care Mapping, and Usual Care in dementia: a cluster-randomised trial

    Lynn Chenoweth;Madeleine T King;Yun-Hee Jeon;Yun-Hee Jeon;Henry Brodaty

  • Evidence-Based Guidelines for Determination of Sample Size and Interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30

    Kim Cocks;Madeleine T. King;Galina Velikova;Galina Velikova;Marrissa Martyn St-James

  • Nursing staffing, nursing workload, the work environment and patient outcomes

    Christine Duffield;Donna Diers;Donna Diers;Linda O'Brien-Pallas;Chris Aisbett

  • A point of minimal important difference (MID): a critique of terminology and methods.

    Madeleine T King

  • Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30.

    K. Cocks;M.T. King;G. Velikova;G. de Castro

  • The importance of patient-reported outcomes in clinical trials and strategies for future optimization

    Rebecca Mercieca-Bebber;Madeleine T King;Melanie J Calvert;Martin R Stockler

  • Quality of life three months and one year after first treatment for early stage breast cancer: influence of treatment and patient characteristics

    M T King;P Kenny;A Shiell;J Hall

  • Psychosocial treatments of behavior symptoms in dementia: a systematic review of reports meeting quality standards.

    Daniel William O'Connor;David J Ames;Betina Kim Gardner;Madeleine King

  • Quality of life three years after diagnosis of localised prostate cancer: population based cohort study.

    David P Smith;Madeleine T King;Sam Egger;Martin P Berry

  • Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations

    T. Luckett;M. T. King;P. N. Butow;M. Oguchi

  • International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.

    Corneel Coens;Madeline Pe;Amylou C. Dueck;Jeff Sloan

  • Review of Adherence-Related Issues in Adolescents and Young Adults With Cancer

    Phyllis Butow;Susan Palmer;Ahna Pai;Belinda Goodenough

  • Time Trade-Off Derived EQ-5D Weights for Australia

    Rosalie Viney;Richard Norman;Madeleine T. King;Paula Cronin

  • Health-related quality of life and physical recovery after a critical illness: a multi-centre randomised controlled trial of a home-based physical rehabilitation program

    Doug Elliott;Sharon McKinley;Jennifer Ailsey Alison;Leanne M Aitken

  • Patient Self-Reports of Symptoms and Clinician Ratings as Predictors of Overall Cancer Survival

    Chantal Quinten;John Maringwa;Carolyn C. Gotay;Francesca Martinelli

  • Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

    Gillian M Duchesne;Henry H Woo;Julie K Bassett;Steven J Bowe

  • Randomized Controlled Trial of the Role of Positron Emission Tomography in the Management of Stage I and II Non-Small-Cell Lung Cancer

    Rosalie C. Viney;Michael J. Boyer;Madeleine T. King;Patricia M. Kenny

  • A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites

    Chantal Quinten;Francesca Martinelli;Corneel Coens;Mirjam A.G. Sprangers

Frequent Co-Authors

Phyllis Butow
Phyllis Butow University of Sydney
Andrew Bottomley
Andrew Bottomley European Organisation for Research and Treatment of Cancer
Michael Friedlander
Michael Friedlander University of New South Wales
Peter Fayers
Peter Fayers University of Aberdeen
Jane Hall
Jane Hall University of Technology Sydney
Bryce B. Reeve
Bryce B. Reeve Duke University
Charles S. Cleeland
Charles S. Cleeland The University of Texas MD Anderson Cancer Center
Joachim Weis
Joachim Weis RWTH Aachen University
David Osoba
David Osoba University of British Columbia
David Goldstein
David Goldstein University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA often begins with research into accessible degree pathways. For those seeking flexible options, affordable nursing programs online offer a cost-effective and convenient entry into healthcare education. These programs are ideal for students balancing work, family, and education.

After becoming a registered nurse, further advancement is possible. Programs like rn to bsn online cost help current RNs earn a Bachelor of Science in Nursing (BSN), which can open doors to more advanced roles and higher salaries.

Those interested in leadership or specialized clinical roles should consider doctoral degrees. The cheapest dnp programs online provide options to pursue a Doctor of Nursing Practice (DNP) remotely, making advanced study more accessible for working professionals.

If you have a non-nursing background but wish to transition into the field, accelerated pathways such as msn direct entry programs online provide a fast track to earning a Master of Science in Nursing. Each route offers unique advantages for aspiring healthcare professionals.

Best Scientists Citing Madeleine King

Trending Scientists